Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

Web

News

Please enter a web search for web results.

News

Web
93.3 The Drive
933thedrive.com > 08/27/2026 > astrazenecas-asthma-drug-tezspire-meets-all-goals-in-late-stage-esophagitis-trial

AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial

5+ hour, 23+ min ago   (321+ words) Aug 27 (Reuters) – AstraZeneca said on Thursday its asthma drug Tezspire met the main goals of a late-stage trial in patients with a chronic inflammatory disorder of the ​oesophagus, offering a boost after a string of pipeline ‌setbacks. The study showed…...

Oncodaily - Oncology News
oncodaily.com > voices > university-of-california-san-diego-571985

University of California San Diego Study Identifies Previously Missed DNA Mutation Pattern in Colorectal Cancer - OncoDaily

2+ hour, 55+ min ago   (186+ words) Researchers from University of California San Diego and collaborators have identified a previously overlooked pattern of DNA mutations in colorectal cancer. Scientists use these patterns, known as mutational signatures, to investigate the biological and environmental processes that have damaged DNA…...

TradingView
tradingview.com > news > tradingview:4b84f8591a5f6:0-roivant-sciences-announces-fda-approval-and-u-s-availability-of-lisraya-for-dermatomyositis

Roivant Sciences Announces FDA Approval and U.S. Availability of LISRAYA for Dermatomyositis

3+ hour, 9+ min ago   (131+ words) TradingView Roivant Sciences Announces FDA Approval and U.S. Availability of LISRAYA for Dermatomyositis Roivant Sciences announced FDA approval of LISRAYA (brepocitinib) for adults with dermatomyositis and immediate U.S. availability. - FDA approved LISRAYA 30 mg (brepocitinib) for adults with dermatomyositis; product available immediately in…...

Gulf Breeze News
news.gulfbreezenews.com > articles > rally-vigil-is-tuesday-at-studer-family-childrens-hospital

Rally vigil is Tuesday at Studer Family Children???s Hospital

12+ hour, 40+ min ago   (131+ words) Rally Gulf Coast will host a heartfelt Candlelight Vigil on Tuesday, Sept. 1, from 6:30 p.m. to 7:30 p.m. outside the main entrance of Studer Family Children’s Hospital at Ascension Sacred Heart, One Bubba Watson Drive, Pensacola. This gathering will honor children affected by childhood…...

PMG-KY1.com
pmg-ky1.com-ky1.com

Brown Cancer Center new facility to serve rural Kentucky

3+ hour, 42+ min ago   (1049+ words) All Hillview mayor Jim Eadens could say about the new cancer center was "WOW". The ribbon was cut Thursday on the UofL Health -- Brown Cancer Center at South Hospital in Hillview Chris Sutton, of Eddyville, makes the 400-mile roundtrip for…...

SheKnows
sheknows.com > health-and-wellness > articles > 12/35/073412 > cheri-oteri-breast-cancer-diagnosis

Cheri Oteri Reveals What 'Shocked' Her About Her Own Reaction to Breast Cancer Diagnosis

3+ hour, 40+ min ago   (443+ words) Cheri Oteri is opening up about her breast cancer diagnosis and the advice that encouraged her to get a second opinion. The 63-year-old Saturday Night Live alum told People that an annual mammogram caught abnormalities earlier this year, leading to…...

U of U Health Publishing Team
healthcare.utah.edu > huntsmancancerinstitute > news > 2026 > 08 > new-targeted-drug-offers-hope-pancreatic-cancer-treatment

New Targeted Drug Offers Hope in Pancreatic Cancer Treatment

10+ hour, 27+ min ago   (63+ words) “KRAS is a driver of 90% of pancreatic cancer cases, and we are now targeting a protein that we couldn’t target before research made this possible.” “We desperately need new therapies for patients with pancreatic cancers. We're at the cusp of…...

Labroots
labroots.com > trending > immunology-and-lymphatic-system > 30968 > bat-genetics-provide-insight-longevity

Bat Genetics Provide Insight into Longevity | Immunology And Lymphatic System

7+ hour, 12+ min ago   (488+ words) Bat Genetics Provide Insight into Longevity Labroots Bat Genetics Provide Insight into Longevity Sudamant is an Associate Professor of Integrative Biology at the University of California, Berkeley (UC Berkeley). His lab uses computational, statistical, and experimental techniques to investigate the…...

Fabry Disease News
fabrydiseasenews.com > news > ptc-acquire-sangamos-gene-therapy-fabry-disease

PTC to acquire Sangamo's gene therapy for Fabry disease

10+ hour, 1+ min ago   (613+ words) Company to seek FDA accelerated approval of one-time therapy Written by Steve Bryson, PhD | Aug. 27, 2026 PTC Therapeutics has been selected as the winning bidder to acquire ST-920 (isaralgagene civaparvovec), a one-time gene therapy candidate for Fabry disease, from the therapy’s…...

Newswise
newswise.com > articles > fda-approval-opens-new-chapter-in-pancreatic-cancer-treatment

FDA Approval Opens New Chapter in Pancreatic Cancer Treatment

5+ hour, 52+ min ago   (749+ words) MIAMI (Aug. 27, 2026) -- For decades, a diagnosis of metastatic pancreatic cancer left patients and physicians facing the same harsh reality: limited options, difficult treatments and too little time. Now, a pill tested in a global clinical trial may begin to change…...